| Authors: |
Maurer MJ; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Prochazka VK; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., El-Galaly TC; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.; Department of Hematology, Odense University Hospital, Odense, Denmark.; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Villa D; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada., Bachy E; Department of Hematology, Lyon Sud Hospital, Lyon, France., Cahn EJ; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Fournier M; Department of Biometry, Lymphoma Study Association Clinical Research (LYSARC), Hopital Lyon Sud, Pierre Benite, France., Larson MC; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Dietrich CE; Division of Clinical Epidemiology, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Jakobsen LH; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Ghesquières H; Department of Hematology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France., Kridel R; Princess Margaret Cancer Centre-UHN, Toronto, Ontario, Canada., Gandhi MK; Mater Research Institute University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia.; Medical School, University of Western Australia, Perth, Australia., Hawkes EA; Olivia Newton John Cancer Research Institute at Austin Health, Melbourne, Australia., Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital & University of Melbourne, Melbourne, Australia., Freeman CL; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Clausen MR; Department of Medicine, Vejle Hospital, Vejle, Denmark., Wahlin BE; Institution for Medicine at Huddinge, Karolinska Institutet and Medical Unit Hematology at Solna, Cancer, Karolinska University Hospital, Stockholm, Sweden., Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, NY., Casulo C; Wilmot Cancer Institute, University of Rochester, Rochester, NY., Habermann TM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Wang Y; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Nastoupil LJ; Southwest Oncology, CommonSpirit Mercy, Durango, CO., de Nully Brown P; Rigshospitalet, Department of Hematology, Copenhagen, Denmark., Belada D; 4th Department of Internal Medicine-Haematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic., Janíková A; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Mocikova H; Fakultni nemocnice Kralovske Vinohrady, Department of Haematology and Third Faculty of Medicine, Charles University, Prague, Czech Republic., Fürst T; Faculty of Science, Palacky University Olomouc, Olomouc, Czech Republic., Feugier P; Department of Hematology; Nancy University Hospital, Vandoeuvre les nancy, France., Tilly H; Department of Hematology and U1245, Centre Henri Becquerel, Rouen, France., Haioun C; Lymphoid Malignancies Unit, Assistante Publique Hôpitaux de Paris APHP, Hopital Henri Mondor, Creteil, France., Davies AJ; Cancer Sciences Division, Somers Cancer Research Building, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Cartron G; Hematology Department, University Hospital, UMR-CNRS553, Montpellier, France., Burack R; University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Rochester, NY., Chihara D; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX., Martin P; Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY., Cohen JB; Department of Hematology and Medical Oncology, Emory University School of Medicine-Winship Cancer Institute, Atlanta, GA., Lossos IS; Lymphoma Section, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL., Kahl BS; Washington University School of Medicine, St Louis, MO., Sehn LH; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada., Smedby KE; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Salles G; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Trneny M; First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic., Link BK; Division of Hematology, Oncology, and Bone and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA., Morschhauser F; Department of Hematology, Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France., Cerhan JR; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN. |
